Nasdaq Crdl News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq crdl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Crdl Today - Breaking & Trending Today
Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 148,800 shares, a growth of 24.4% from the January 15th total of 119,600 shares. Based on an average trading volume of 163,400 shares, […] ....
Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) and CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Earnings & Valuation This table compares Cardiol […] ....
Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 325,100 shares, a growth of 32.1% from the September 30th total of 246,100 shares. Approximately 0.5% of the shares of the company are short sold. Based […] ....
Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 106,100 shares, an increase of 46.5% from the August 31st total of 72,400 shares. Currently, 0.2% of the company’s shares are short sold. Based on an […] ....
Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) and Aura Biosciences (NASDAQ:AURA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability. Volatility and Risk Cardiol Therapeutics has a […] ....